MP
Matthew L. Posard (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Halozyme Therapeutics, Inc. (HALO). The largest single filing was $2.0M of HALO (18,996 sh across 4 lots, as filed), executed Sep 16. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.5M
shares × price, as filed
Last traded
Oct 1
Filed Oct 2
Median ADV $214.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
HALORecent filings
HALOSALE
Halozyme Therapeutics, Inc.
View filing →
$478K4,400 sh across 2 lots
Exec Oct 1
Filed Oct 2 · 4:38 PM ET HALOSALE Halozyme Therapeutics, Inc. View filing → $2.0M
18,996 sh across 4 lots
Exec Sep 16
Filed Sep 17 · 5:19 PM ET